In the study by Batlle et al. (2005) EPHB2 activity was observed to suppress CRC progression as the disruption of EphB2 in Apcmin/+ mice was shown to accelerate tumor formation and growth in colon and rectum [5]. This evidence concerns the gene EPHB2 and colorectal carcinoma.